Emad Zarief Kamel Said
Asyut, 71111, Egypt
NCT Number: NCT02715869
Preconditioning (PC) of the heart occurs when brief exposure to a stimulus protects the heart from subsequent ischemia. PC stimulus may be (ischemic ; pharmacologic or Physical).
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Asyut, 71111, Egypt
Preconditioning (PC) of the heart occurs when brief exposure to a stimulus protects the heart from subsequent ischemia. PC stimulus may be ( ischemic ; pharmacologic or Physical)
Pharmacological PC may be induced by variable agents e.g. (Sevoflurane ;isoflorane, opioids etc)
Ischemic PC includes local; remote and the idea is temporary interruption of blood supply to the organ so that liberation of protective mediators occurs. The liberated mediators have favorable effects not only upon the myocardium, but it extend to protect other organs against inflammatory activation; ischemia reperfusion injury
Inotropic score (IS) is already an evident predictor of postoperative cardiac morbidity and mortality
Aim of the work:
Is to validate the impact of Sevoflurane versus ischemic & Sevoflurane PC upon postoperative inotropic score in adult patient undergoing open heart surgery
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A Patients are anaesthetized by Sevoflurane more than 1 mac.
B ischemic preconditioning will be done after induction and before cardiopulmonary bypass by inflation the cuff of blood pressure above 200mmhg in the lower limb every 5 min for 3cycles
Time frame: first 24 hour
Assiut University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT05584280
Cardiovascular Diseases, Heart Diseases
Gothenburg, Sweden
View Trial DetailsNCT02694185
Behavior, Cardiovascular Diseases
San Francisco, California, United States
View Trial DetailsNCT06345573
Behavior, Behavioral Symptoms
Zurich, Canton of Zurich, Switzerland
View Trial Details